Several GOP lawmakers took aim at CMMI for its plan to slash Medicare payments to drugs cleared under the Food and Drug Administration’s accelerated approval program.
The White House is expected to announce the selection of Dr. Monica M. Bertagnolli, who last year became the director of the National Cancer Institute, in the coming days.